Wenzhao Zhong, MD, PhD
Department of Pulmonary Oncology, Guangdong Lung Cancer Institute & Guangdong General Hospital, Guangzhou, China
Dr. Wen-Zhao Zhong is a professor, PhD supervisor and majors in surgical oncology of lung cancer. He is Deputy director of Guangdong Lung Cancer Institute, Professor of the Guangdong General Hospital& Guangdong Academy of Medical Sciences, core member of Chinese Society of Clinical Oncology（CSCO）and a member of the International Association Study of Lung Cancer(IASLC). He is Principal Investigator of three projects supported by National Natural Science Foundation of China and the co-PI of the ADJUVANT-CTONG 1104 study (https://am.asco.org/adjuvant-gefitinib-extend-dfs-nsclc-egfr-activating-mutations).
He has published more than 30 articles in journals such as J Clin Oncol, Cancer, Oncolmmunology, CCR, Oncologist, J Thorac Oncol, Lung Cancer, JHO, Eur J Cardiothorac Surg, Ann Surg Oncol, BMC Cancer, Clin Lung Cancer, Cancer Lett, JTD and TCR, etc. His research interests include tumor evolution mechanism, tumor heterogeneity, and indolent lung cancer, clinical trial of peri-operative therapy of resectable lung cancer and AI in lung cancer diagnosis. He is one of the associate editors of J Thorac Oncol (http://www.jto.org/content/edboard ) and Translational lung cancer research (http://tlcr.amegroups.com/user/view/801 ).